Drugs & OTC

MMJ Group Holdings Ltd (ASX:MMJ) Harvest One Cannabis Investor Presentation

🕔9/20/2019 5:11:34 PM

MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) are pleased to provide the presentation which was delivered by Harvest One Cannabis Inc (OTCMKTS:HRVOF) (CVE:HVT) at the KCSA Cannabis Investor Conference on 12 September 2019.

Read Full Article

BPH Energy Ltd (ASX:BPH) Medicinal Cannabis Investment Market Update

🕔9/17/2019 2:34:00 PM

BPH Energy Ltd (ASX:BPH) is pleased to provide market update in relation to developments for its Medicinal Cannabis investment Patagonia Genetics.

Read Full Article

MMJ Group Holdings Ltd (ASX:MMJ) 31 August 2019 Net Tangible Asset Backing

🕔9/12/2019 3:24:30 PM

MMJ Group Holdings Ltd (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) provide the 31 August 2019 Net Tangible Asset Backing.

Read Full Article

Cann Global Limited (ASX:CGB) Asia Distribution Update

🕔9/9/2019 8:19:38 AM

The Board of Cann Global Limited (ASX:CGB) is pleased to provide an update on its recent exclusive distributorship supply contract deal signed with EPCO Foods Co. Ltd in Ho Chi Minh City, Vietnam.

Read Full Article

Cann Global Limited (ASX:CGB) T12 Signs Exclusive Vietnam Distributorship

🕔9/5/2019 9:31:32 AM

The Board of Cann Global Limited (ASX:CGB) is pleased to announce that its T12 Food Division, under managers Sebastian and Samuel Edwards, have just signed an exclusive distributorship contract with EPCO Foods Co. Ltd in Ho Chi Minh City, Vietnam.

Read Full Article

THC Global Group Limited (ASX:THC) Secures 24.6ha Cannabis Cultivation Site

🕔9/5/2019 9:20:12 AM

THC Global Group Limited (ASX:THC) (FRA:9TH) (OTCMKTS:HDRPF) advises that it has secured an agreement to lease a property with 66,000m2 of existing hydroponics greenhouses, and an additional 180,000m2 of agricultural land for the cultivation of medicinal cannabis in Bundaberg, Queensland.

Read Full Article

THC Global Group Limited (ASX:THC) Half Yearly Report and Accounts

🕔9/2/2019 10:25:34 AM

THC Global Group Limited (ASX:THC) operates under a 'Farm to Pharma' pharmaceutical model and is currently delivering high quality medicinal cannabis products to Australian patients through existing access schemes.

Read Full Article